Allergan Sues Watson Over Sanctura Incontinence Drug

Allergan Inc., the maker of wrinkle-smoothing Botox, sued Watson Pharmaceuticals Inc., alleging infringement of a U.S. patent for Sanctura XR, a prescription medicine used to treat overactive bladder.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.